Kornitzer Capital Management Inc Nektar Therapeutics Transaction History

Kornitzer Capital Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 02, 2018	SELL	$46.25 - $104.45 $4.7 Million - $10.6 Million	-101,655 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$57.4 - $108.44 $1.9 Million - $3.59 Million	33,095 Added 48.27%	101,655 $10.8 Million
Q4 2017 Jan 31, 2018	BUY	$23.02 - $60.5 $1.58 Million - $4.15 Million	68,560	68,560 $4.09 Million

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $191M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.